Judge throws book at Daniel Chapter One
This article was originally published in The Tan Sheet
Executive Summary
An administrative judge upholds the Federal Trade Commission's charges that supplement marketer Daniel Chapter One falsely advertised its shark cartilage and herbal formulations prevent, treat and cure cancer. The judge found the firm could not substantiate its claims with reliable scientific evidence and ordered the company to stop making false claims. FTC charged Daniel Chapter One with deceptive advertising in 2008 in an enforcement sweep that charged 11 firms with marketing false cancer remedies (1"The Tan Sheet" Sept. 22, 2008)
You may also be interested in...
FTC affirms cancer cures case ruling
Daniel Chapter One must notify customers it made deceptive and unsubstantiated cancer cure claims for its herbal products after failing in its appeal of an administrative law judge's ruling to uphold Federal Trade Commission charges. The commission's unanimous 1opinion, announced Dec. 24, says respondents Daniel Chapter One and James Feijo "lacked a reasonable basis to substantiate" claims their products BioShark, 7 Herb Formula and others inhibit tumor growth and are effective cancer treatments. Like other companies charged in FTC's 2008 enforcement sweep against bogus cancer cure claims, Providence, R.I.-based Daniel Chapter One is enjoined from making such claims without supporting scientific evidence (2"The Tan Sheet" Aug. 17, 2009, In Brief)
Cancer Claims Continue Attracting Federal Enforcement Actions
Herbal and supplement products allegedly making deceptive cancer cure claims prompted the Federal Trade Commission to file complaints against 11 firms, including five that rejected settlement offers and are contesting the complaints
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.